André Marette
Chercheur universitaire
Axe Endocrinologie et néphrologie
Publications
View all-
article Mokrani M, Le Barz M, Elie AM, Renouf É and Mérillon JM, Limam F, Aouani E, Marette A, Saad N, Urdaci MC
Prevention of Intestinal Inflammation and Gut Dysbiosis by Prebiotic Grape Seed Flour in Mice with DSS-Induced Colitis
Pharmaceuticals (Basel) 19 (8), 2026.
-
article Chavanelle V, F Otero Y, Fayat Cazaubiel M, Bard JM, Pereira B, Sapone V, Bouchard-Mercier A, Bargetto M, Boisseau N, Guigas B, Peltier S, Le Joubioux F, Maugard T, Hadjadj S, Sirvent P, Marette A
Totum-63, a plant-based polyphenol-rich extract, in prediabetes or early-stage type 2 diabetes: an international, multicenter, randomized controlled trial
Nat Commun 17 (1), 2026.
-
article Beji S, Mouchiroud M, Tribouillard L, Efole B, Perazza L, Favereaux L, Poirier A, Idris W, Gélinas Y, Varin TV, Rovère C, Anhê FF, Picard F, Laplante M, Marette A, Michaud A, Caron A
Proanthocyanidin-Rich Cranberry Extract Lowers Glycemia in Established Obesity by Delaying Glucose Absorption
FASEB J 40 (12), 2026.
Projects
- Valorisation Intégrée des co-produits par des Technologies ALimentaires écoefficientes dans le cadre d'une Économie circulaire (Consortium VITALE), from 2021-04-15 to 2028-12-31
- Host iNOS dictates gut dysbiosis, bacterial translocation and tissue insulin resistance in murine and human obesity, from 2022-07-01 to 2027-06-30
- Fonds de recherche Pfizer sur la pathogenèse de la résistance à l’insuline et des maladies cardiovasculaires, from 2022-05-01 to 2027-04-30
- Role of altered production of branched-chain hydroxy acids (BCHA) in the pathogenesis of type 2 diabetes (T2D) and fatty liver disease and its prevention by BCHA-supplemented yogurt, from 2023-04-01 to 2028-03-31
- Nutrient sensing mechanisms underlying the metabolic effects of dietary proteins in obesity and type 2 diabetes, from 2023-10-01 to 2028-09-30
- Comparaison des effets métaboliques d’isolats protéiques de caséines et de pois et de fromages et analogues végétaux de fromages élaborés à partir de ces isolats à l'aide de modèles in vitro et in vivo humanisés, from 2024-01-01 to 2027-04-30
- Institut sur la nutrition et les aliments fonctionnels, from 2024-04-01 to 2030-03-31
- Chaire Valbiotis sur la recherche translationnelle des mécanismes d’action de composés végétaux sur la stéatose hépatique métabolique, from 2024-01-04 to 2029-01-03
- Identification of microbial biomarkers associated with semaglutide-induced weight loss response, from 2025-01-01 to 2027-03-31
- Microbial determinants of the therapeutic response to ellagitannin polyphenols for hepatic steatosis, from 2024-12-01 to 2027-03-31
- Efficacité d'une intervention basée sur le coaching parental et l'analyse de la perception sensorielle des aliments chez les enfants autiste, from 2024-12-18 to 2027-12-17
- Effects of cranberry on gut and metabolic health, from 2025-02-13 to 2027-12-31
- Une nouvelle classe d’analogues lipidiques pour la résolution des maladies hépatiques inflammatoires (Marette), from 2025-06-09 to 2027-12-31
- Une nouvelle classe d’analogues lipidiques pour la résolution des maladies hépatiques inflammatoires, from 2025-06-09 to 2027-12-31
- Role of GPR37 in the therapeutic action of protectin DX and a new synthetic analogue against type 2 diabetes and related complications, from 2026-01-01 to 2028-12-31
- Harnessing the gut microbiome-prostate cancer crosstalk and its modulation by long-chain omega-3 to discover predictive biomarkers of risk and potential preventive strategies, from 2025-11-01 to 2030-10-31
- Découverte et caractérisation d'effets de nouveaux -biotiques sur la santé cardiométabolique et neurognitive au cours du vieillissement, from 2026-03-17 to 2029-03-17
- Impact d’un remplacement de sucre raffiné par du sirop d’érable sur les facteurs de risque cardiométabolique, from 2019-01-01 to 2024-12-31
- Développement de procédés verts pour la production et la concentration d'extraits de biomasses végétales et marines, et évaluation de leur potentiel anti-microbien et anti-biofilm, from 2020-01-31 to 2024-11-30
- Programme de recherche sur la valorisation de biomasses marines et végétales et objectivation d’ingrédients bioactifs, from 2020-01-31 to 2024-11-30
- Dissecting host-microbiome modifiers of type 2 diabetes risk, from 2019-11-01 to 2024-10-31
- Antimicrobial resistance genes in bioaerosols in Canadian arctic, rural, and urban environments: sources, profiles, transport and fate, from 2019-12-01 to 2025-11-30
- Prebiotics to modify the gut microbiome and enhance immune checkpoint blockers, from 2019-10-01 to 2024-09-30
- Interactions between Nordic environment and Chronobiotics: Impact on cardiometabolic and neurometabolic health, from 2020-11-01 to 2024-12-31
- Extreme zooming on intestinal permeability and the western-style diet: Unravelling the role of dietary antigens on the prevalence of cardiometabolic and mental health diseases in the North, from 2020-11-01 to 2024-12-31
- Dissecting host-microbiome modifiers of type 2 diabetes risk - Objective 3.2, from 2019-11-01 to 2024-10-31
- Dissecting host-microbiome modifiers of type 2 diabetes risk - Transferts interinstitutionnels, from 2019-11-01 to 2024-10-31
- Dissecting host-microbiome modifiers of type 2 diabetes risk - Objective 1.2, from 2019-11-01 to 2024-10-31
- Dissecting host-microbiome modifiers of type 2 diabetes risk - Objective 1.3, from 2019-11-01 to 2024-10-31
- Dissecting host-microbiome modifiers of type 2 diabetes risk - Objective 1.1, from 2019-11-01 to 2024-10-31
- Multiparametric MRI for the investigation of coronary microvascular disease, from 2022-05-12 to 2026-04-30
- A new focus on protein and the gut microbiota to explain health benefits of dairy foods, from 2022-01-01 to 2026-06-30
- Aim 3b - Antimicrobial resistance genes in bioaerosols in Canadian arctic, rural, and urban environments: sources, profiles, transport and fate, from 2022-01-27 to 2025-11-30
- Validation de la mesure d’expression génique unicellulaire à partir d’un échantillon de tissu hépatique chez des sujets avec une suspicion clinique de stéatose hépatique non-alcoolique., from 2022-08-24 to 2025-03-31
- Nanomatériaux pour cibler le microbiote intestinal et altérer le métabolisme des acides biliaires, from 2023-04-01 to 2026-03-31
- Mitochondria bound to lipid droplets as new regulators of insulin resistance, from 2022-12-01 to 2026-06-30
- Économie salariale générée par la subvention NIH 131733 utilisée en fonds de recherche, from 2022-05-12 to 2026-04-30
- Demonstration of the prebiotic effects of camu-camu consumption against obesity-related disorders in humans, from 2023-11-01 to 2025-04-30
- Screening the functional impact of bacterial strains in the liver and adipose tissue of people with obesity and type 2 diabetes using nematode and murine models, from 2025-01-01 to 2026-03-31
- Effects of egg yolk granule fractions exposed to high hydrostatic pressure on the metabolic health of obese mice, from 2024-11-22 to 2025-11-21
- Dietary protein impact on post-prandial hepatic metabolic fluxes, from 2025-05-11 to 2025-11-11